Clinical Study
Effect of Teriparatide on Unstable Pertrochanteric Fractures
Table 2
Postoperative complications of patients in the control and teriparatide groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Group A: patients without supplementary pharmacologic treatment. Group B: patients treated with teriparatide. The values are given as the (%). values for between-group comparisons were determined by the chi-squared test and Fisher’s exact test for nominal variables and Student’s -test for parametric variables. Statistically significant ( value < 0.05). |